Table 1.
Distribution of HBoV single infection and co-infection with other viruses
|
Type of infection |
Virus |
No. of patients (%) |
Subtotal (%) |
||||
|---|---|---|---|---|---|---|---|
|
Single infection |
HBoV (only) |
48 (43.2) |
48 (43.2) |
||||
|
Co-infection |
HBoV |
RSV |
12 (10.8) |
63 (56.8) |
|||
|
HBoV |
HRV |
11 (9.9) |
|||||
|
HBoV |
IAV |
7 (6.3) |
|||||
|
HBoV |
ADV |
4 (3.6) |
|||||
|
HBoV |
HCoV (OC43) |
3 (2.7) |
|||||
|
HBoV |
HMPV |
3 (2.7) |
|||||
|
HBoV |
HRV |
RSV |
2 (1.8) |
||||
|
HBoV |
HDV |
HRV |
2 (0.8) |
||||
|
HBoV |
PIV3 |
1 (0.9) |
|||||
|
HBoV |
PIV3 |
ENT |
1 (0.9) |
||||
|
HBoV |
PIV3 |
RSV |
1 (0.9) |
||||
|
HBoV |
HCoV (OC43) |
HSV1 |
1 (0.9) |
||||
|
HBoV |
HCoV (64) |
1 (0.9) |
|||||
|
HBoV |
HCoV (OC43) |
RSV |
1(0.9) |
||||
|
HBoV |
HCoV (OC43) |
ADV |
ENT |
1 (0.9) |
|||
|
HBoV |
IBV |
1 (0.9) |
|||||
|
HBoV |
HCoV (NL63) |
1 (0.9) |
|||||
|
HBoV |
HCoV (64) |
IAV |
1 (0.9) |
||||
|
HBoV |
ENT |
1 (0.9) |
|||||
|
HBoV |
IAV (H1N1) |
1 (0.9) |
|||||
|
HBoV |
IBV |
RSV |
1 (0.9) |
||||
|
HBoV |
HPeV |
RSV |
1 (0.9) |
||||
|
HBoV |
HRV |
HCoV (OC43) |
PIV3 |
RSV |
1 (0.9) |
||
|
HBoV |
HRV |
ENT |
1 (0.9) |
||||
|
HBoV |
HRV |
IAV |
RSV |
1 (0.9) |
|||
|
HBoV |
HRV |
PIV3 |
HPeV |
1 (0.9) |
|||
|
HBoV |
HCoV (OC43) |
HRV |
1 (0.9) |
||||
|
Total |
111 (100) |
||||||
HBoV, human bocavirus; HRV, human rhinovirus; RSV, respiratory syncytial virus; IAV, influenza A virus; ADV, adenovirus; PIV, parainfluenza virus; ENT, enterovirus; HCoV, human coronavirus; HMPV, human metapneumovirus; HSV, human simplex virus; IBV, influenza virus B virus; HPeV, parechovirus.